Applied DNA Sciences
APDN
#9954
Rank
$9.1 M
Marketcap
$0.17
Share price
-1.61%
Change (1 day)
-98.60%
Change (1 year)
Categories

P/E ratio for Applied DNA Sciences (APDN)

P/E ratio as of December 2024 (TTM): -0.3633

According to Applied DNA Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.363333. At the end of 2022 the company had a P/E ratio of -51.1.

P/E ratio history for Applied DNA Sciences from 2003 to 2023

2005201020152020-400-2002004000companiesmarketcap.com

PE ratio at the end of each year

Year P/E ratio Change
2022-51.123.25%
2021-41.428.8%
2020-32.2175.31%
2019-11.7-41.56%
2018-20.0-71.7%
2017-70.73.14%
2016-68.5-64.05%
2015-191229.74%
2014-57.8-62.48%
2013-154-36.16%
2012-241602.06%
2011-34.4-42.72%
2010-60.0-200%
200960.0-340%
2008-25.037.5%
2007-18.2-54.55%
2006-40.0209.51%
2005-12.9-56.18%
2004-29.5-70.92%
2003-101

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
38.3-10,652.41%๐Ÿ‡บ๐Ÿ‡ธ USA
17.1-4,802.41%๐Ÿ‡บ๐Ÿ‡ธ USA
23.7-6,636.26%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.